Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T05876 | Target Info | |||
Target Name | Ebola virus Envelope glycoprotein (EV GP) | ||||
Synonyms | GP1,2; GP | ||||
Target Type | Successful Target | ||||
Gene Name | EV GP | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Sertraline | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH SERTRALINE | PDB:6F6N | ||||
Method | X-ray diffraction | Resolution | 2.15 Å | Mutation | Yes | [1] |
PDB Sequence |
.
|
|||||
|
||||||
Ligand Name: Clomipramine | Ligand Info | |||||
Structure Description | Crystal structure of Ebolavirus glycoprotein in complex with clomipramine | PDB:6G9I | ||||
Method | X-ray diffraction | Resolution | 2.19 Å | Mutation | Yes | [2] |
PDB Sequence |
.
|
|||||
|
||||||
Ligand Name: Imipramine | Ligand Info | |||||
Structure Description | Crystal structure of Ebolavirus glycoprotein in complex with imipramine | PDB:6G9B | ||||
Method | X-ray diffraction | Resolution | 2.26 Å | Mutation | Yes | [2] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .IXX or .IXX2 or .IXX3 or :3IXX;style chemicals stick;color identity;select .A:36 or .A:37 or .A:38 or .A:43 or .A:66 or .A:184 or .A:185 or .A:186 or .A:187 or .A:64 or .A:101 or .A:186 or .B:515 or .B:548 or .B:554 or .B:555 or .B:558 or .B:517 or .B:519 or .B:521 or .B:544 or .B:548; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLY36[A]
4.499
VAL37[A]
4.870
ILE38[A]
3.434
LEU43[A]
3.500
VAL66[A]
3.940
LEU184[A]
3.559
ILE185[A]
3.677
LEU186[A]
3.535
PRO187[A]
4.038
ARG64[A]
3.053
ALA101[A]
3.764
|
|||||
Ligand Name: Paroxetine | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH PAROXETINE | PDB:6F6I | ||||
Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | Yes | [1] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .8PR or .8PR2 or .8PR3 or :38PR;style chemicals stick;color identity;select .A:64 or .A:65 or .A:66 or .A:67 or .A:68 or .A:100 or .A:101 or .A:102 or .A:103 or .A:184 or .A:186 or .B:515 or .B:517 or .B:518 or .B:519 or .B:548 or .B:558; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG64[A]
3.284
SER65[A]
4.637
VAL66[A]
3.278
GLY67[A]
3.288
LEU68[A]
3.542
GLU100[A]
3.525
ALA101[A]
3.475
GLY102[A]
3.359
GLU103[A]
4.299
|
|||||
Ligand Name: Ibuprofen | Ligand Info | |||||
Structure Description | Crystal structure of Ebola glycoprotein in complex with ibuprofen | PDB:5JQB | ||||
Method | X-ray diffraction | Resolution | 2.68 Å | Mutation | Yes | [3] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .IBP or .IBP2 or .IBP3 or :3IBP;style chemicals stick;color identity;select .A:38 or .A:43 or .A:64 or .A:66 or .A:101 or .A:184 or .A:186 or .B:515 or .B:517 or .B:519 or .B:548 or .B:554 or .B:558; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: Toremifene | Ligand Info | |||||
Structure Description | Crystal structure of Ebola glycoprotein in complex with toremifene | PDB:5JQ7 | ||||
Method | X-ray diffraction | Resolution | 2.69 Å | Mutation | Yes | [3] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .T0R or .T0R2 or .T0R3 or :3T0R;style chemicals stick;color identity;select .A:64 or .A:66 or .A:67 or .A:68 or .A:100 or .A:101 or .A:102 or .A:103 or .A:184 or .A:186 or .B:515 or .B:517 or .B:519 or .B:520 or .B:521 or .B:522 or .B:548 or .B:554 or .B:558; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG64[A]
3.585
VAL66[A]
3.216
GLY67[A]
4.291
LEU68[A]
3.975
GLU100[A]
3.560
ALA101[A]
3.592
GLY102[A]
3.746
GLU103[A]
4.915
LEU184[A]
3.660
LEU186[A]
3.712
|
|||||
Ligand Name: Benztropine | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH benztropine | PDB:6F6S | ||||
Method | X-ray diffraction | Resolution | 2.29 Å | Mutation | Yes | [1] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CXQ or .CXQ2 or .CXQ3 or :3CXQ;style chemicals stick;color identity;select .A:64 or .A:101 or .A:186 or .A:38 or .A:43 or .A:66 or .A:101 or .A:184 or .A:186 or .A:187 or .B:517 or .B:519 or .B:521 or .B:544 or .B:515 or .B:517 or .B:548 or .B:554 or .B:555 or .B:558; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG64[A]
3.052
ALA101[A]
3.678
LEU186[A]
4.462
ILE38[A]
4.031
LEU43[A]
4.327
VAL66[A]
3.604
ALA101[A]
4.670
LEU184[A]
3.717
LEU186[A]
3.539
PRO187[A]
4.326
|
|||||
Ligand Name: Alpha-D-Mannose | Ligand Info | |||||
Structure Description | EM structure of a EBOV-GP bound to 3T0331 neutralizing antibody | PDB:6QD7 | ||||
Method | Electron microscopy | Resolution | 3.10 Å | Mutation | No | [4] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MAN or .MAN2 or .MAN3 or :3MAN;style chemicals stick;color identity;select .A:84 or .A:155 or .A:156; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 1-(2-(3-hydroxy-4-(4-phenyl-1H-pyrazol-3-yl)phenoxy)ethyl)piperidine-4-carboxamide | Ligand Info | |||||
Structure Description | Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118 | PDB:6HS4 | ||||
Method | X-ray diffraction | Resolution | 2.05 Å | Mutation | Yes | [5] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GON or .GON2 or .GON3 or :3GON;style chemicals stick;color identity;select .A:38 or .A:43 or .A:60 or .A:61 or .A:63 or .A:64 or .A:65 or .A:66 or .A:68 or .A:100 or .A:101 or .A:102 or .A:184 or .A:186 or .A:187 or .A:189 or .B:515 or .B:517 or .B:519 or .B:520 or .B:522 or .B:548 or .B:554 or .B:555 or .B:558; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE38[A]
3.876
LEU43[A]
4.185
THR60[A]
4.412
ASN61[A]
3.230
LEU63[A]
4.959
ARG64[A]
3.506
SER65[A]
4.928
VAL66[A]
3.494
LEU68[A]
4.940
GLU100[A]
3.315
ALA101[A]
3.671
GLY102[A]
4.473
LEU184[A]
4.130
|
|||||
Ligand Name: 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide | Ligand Info | |||||
Structure Description | Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a | PDB:6HRO | ||||
Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | Yes | [5] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GKZ or .GKZ2 or .GKZ3 or :3GKZ;style chemicals stick;color identity;select .A:38 or .A:43 or .A:64 or .A:184 or .A:186 or .A:187 or .A:189 or .A:190 or .A:191 or .A:60 or .A:61 or .A:63 or .A:64 or .A:66 or .A:67 or .A:68 or .A:100 or .A:101 or .A:102 or .A:103 or .B:548 or .B:554 or .B:558 or .B:515 or .B:517 or .B:518 or .B:519 or .B:520 or .B:522 or .B:548 or .B:558; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE38[A]
3.821
LEU43[A]
4.052
ARG64[A]
4.392
LEU184[A]
4.502
LEU186[A]
3.509
PRO187[A]
3.292
ALA189[A]
2.945
LYS190[A]
3.506
LYS191[A]
3.667
THR60[A]
3.941
ASN61[A]
3.173
LEU63[A]
4.866
ARG64[A]
3.356
VAL66[A]
3.537
GLY67[A]
3.142
LEU68[A]
4.013
|
|||||
Ligand Name: Bepridil, (R)- | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH BEPRIDIL | PDB:6F5U | ||||
Method | X-ray diffraction | Resolution | 2.07 Å | Mutation | Yes | [1] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CQN or .CQN2 or .CQN3 or :3CQN;style chemicals stick;color identity;select .A:38 or .A:43 or .A:64 or .A:66 or .A:67 or .A:68 or .A:100 or .A:101 or .A:102 or .A:184 or .A:186 or .B:515 or .B:517 or .B:519 or .B:548 or .B:554 or .B:555 or .B:558; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE38[A]
4.601
LEU43[A]
4.001
ARG64[A]
3.129
VAL66[A]
3.473
GLY67[A]
4.586
LEU68[A]
4.432
GLU100[A]
4.775
ALA101[A]
3.486
GLY102[A]
3.859
|
|||||
Ligand Name: 10-{2-[(2r)-1-Methylpiperidin-2-Yl]ethyl}-2-(Methylsulfanyl)-10h-Phenothiazine | Ligand Info | |||||
Structure Description | Crystal structure of Ebolavirus glycoprotein in complex with thioridazine | PDB:6G95 | ||||
Method | X-ray diffraction | Resolution | 2.31 Å | Mutation | Yes | [2] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .RTZ or .RTZ2 or .RTZ3 or :3RTZ;style chemicals stick;color identity;select .A:36 or .A:37 or .A:38 or .A:43 or .A:66 or .A:101 or .A:184 or .A:185 or .A:186 or .A:187 or .B:515 or .B:517 or .B:548 or .B:549 or .B:554 or .B:555 or .B:558; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLY36[A]
3.133
VAL37[A]
3.504
ILE38[A]
3.648
LEU43[A]
3.442
VAL66[A]
4.001
ALA101[A]
4.121
LEU184[A]
3.675
ILE185[A]
2.959
LEU186[A]
3.679
|
|||||
Ligand Name: (1R,3S,5S,7S)-N-[(1r,4R)-4-aminocyclohexyl]-3-[(methylsulfanyl)methyl]-5-phenyladamantane-1-carboxamide | Ligand Info | |||||
Structure Description | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146 | PDB:7LYD | ||||
Method | X-ray diffraction | Resolution | 2.35 Å | Mutation | Yes | [6] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .YOD or .YOD2 or .YOD3 or :3YOD;style chemicals stick;color identity;select .A:38 or .A:61 or .A:64 or .A:66 or .A:67 or .A:68 or .A:101 or .A:102 or .A:103 or .A:184 or .A:186 or .A:187 or .B:515 or .B:517 or .B:519 or .B:520 or .B:521 or .B:522 or .B:544 or .B:548 or .B:554 or .B:558; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE38[A]
4.190
ASN61[A]
4.949
ARG64[A]
3.111
VAL66[A]
3.396
GLY67[A]
3.620
LEU68[A]
4.066
ALA101[A]
3.750
GLY102[A]
3.647
GLU103[A]
4.468
LEU184[A]
4.227
LEU186[A]
3.497
|
|||||
Ligand Name: (1R,3S,5R,7R)-N-[(1r,4R)-4-aminocyclohexyl]-3-(ethoxymethyl)-5-phenyladamantane-1-carboxamide | Ligand Info | |||||
Structure Description | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953 | PDB:7M2D | ||||
Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | Yes | [7] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .YPS or .YPS2 or .YPS3 or :3YPS;style chemicals stick;color identity;select .A:38 or .A:43 or .A:64 or .A:66 or .A:67 or .A:68 or .A:101 or .A:102 or .A:103 or .A:184 or .A:186 or .B:515 or .B:517 or .B:519 or .B:520 or .B:521 or .B:522 or .B:544 or .B:548 or .B:554 or .B:558; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE38[A]
4.125
LEU43[A]
4.941
ARG64[A]
3.040
VAL66[A]
3.374
GLY67[A]
3.661
LEU68[A]
4.053
ALA101[A]
3.827
GLY102[A]
3.556
GLU103[A]
4.404
LEU184[A]
4.067
LEU186[A]
3.544
|
|||||
Ligand Name: (1s,3R,5S,7s)-N-[(1r,4r)-4-aminocyclohexyl]-3,5-diphenyladamantane-1-carboxamide | Ligand Info | |||||
Structure Description | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075164 | PDB:7LYY | ||||
Method | X-ray diffraction | Resolution | 2.75 Å | Mutation | Yes | [8] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .YPM or .YPM2 or .YPM3 or :3YPM;style chemicals stick;color identity;select .A:38 or .A:64 or .A:66 or .A:67 or .A:68 or .A:101 or .A:102 or .A:103 or .A:184 or .A:186 or .A:187 or .B:515 or .B:517 or .B:519 or .B:520 or .B:521 or .B:522 or .B:544 or .B:548 or .B:554 or .B:558; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE38[A]
3.758
ARG64[A]
3.165
VAL66[A]
3.320
GLY67[A]
3.800
LEU68[A]
3.847
ALA101[A]
3.865
GLY102[A]
3.628
GLU103[A]
4.539
LEU184[A]
3.568
LEU186[A]
3.818
PRO187[A]
4.419
|
|||||
Ligand Name: (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide | Ligand Info | |||||
Structure Description | Crystal Structure of Ebola zaire GP protein with bound ARN0074898 | PDB:6NAE | ||||
Method | X-ray diffraction | Resolution | 2.75 Å | Mutation | Yes | [9] |
PDB Sequence |
.
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KHG or .KHG2 or .KHG3 or :3KHG;style chemicals stick;color identity;select .A:64 or .A:66 or .A:67 or .A:68 or .A:101 or .A:102 or .A:103 or .A:184 or .A:186 or .B:515 or .B:517 or .B:518 or .B:519 or .B:544 or .B:548 or .B:558; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection. J Med Chem. 2018 Feb 8;61(3):724-733. | ||||
REF 2 | Structures of Ebola Virus Glycoprotein Complexes with Tricyclic Antidepressant and Antipsychotic Drugs. J Med Chem. 2018 Jun 14;61(11):4938-4945. | ||||
REF 3 | Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature. 2016 Jul 7;535(7610):169-172. | ||||
REF 4 | Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nat Med. 2019 Oct;25(10):1589-1600. | ||||
REF 5 | Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library. J Med Chem. 2019 Mar 28;62(6):2928-2937. | ||||
REF 6 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146 | ||||
REF 7 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953 | ||||
REF 8 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075164 | ||||
REF 9 | Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors. ACS Med Chem Lett. 2020 May 1;11(6):1160-1167. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.